Memantine: a new hope for treatment of Lewy body-related dementias?
Emre
Murat
M
D000368:Aged; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004347:Drug Interactions / Q000502:physiology; D018691:Excitatory Amino Acid Antagonists / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D020961:Lewy Body Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D008559:Memantine / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D015990:Placebo Effect; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
D018691:Excitatory Amino Acid Antagonists; D018698:Glutamic Acid; D008559:Memantine